<DOC>
	<DOC>NCT00700661</DOC>
	<brief_summary>A study to determine the efficacy of MK0476 in the Treatment of Asthmatic Patients Aged 2 to 5 Years.</brief_summary>
	<brief_title>A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Male or Female between and including the ages of 2 and 5 years Patient was treated with steroids for an asthma episode in the last 3 months Patient was admitted to the hospital or emergency room in the last 3 months Patient is able to chew a tablet Patient has been in a research study in the past 4 weeks Patient has visited the emergency room for an asthma episode in the past week Patients has a history of stomach, heart, liver, nerve, kidney or blood disease</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>